Progyny, Inc. (PGNY)
Nasdaq: PGNY · Services-Misc Health & Allied Services, NEC · New York, NY · filing with the SEC since 2012
Grade6.6
◀ Past 8.4● Present 6.3▶ Future 5.2
Who owns Progyny, Inc.
As filed with the SECHolders of 5% or more
4
Blackrock, Inc. holds 14.7% of Common Stock, as its SCHEDULE 13G/A filed Oct 27, 2026 says.
Directors and officers
15
report now, of 22 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Oct 27, 2026 · Common Stock · 13% in Apr 28, 2025
Fmr LLC
SCHEDULE 13G/A · filed Aug 6, 2026 · COMMON STOCK · 7.6% in Nov 5, 2025
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Thrivent Financial For Lutherans
SCHEDULE 13G · filed Apr 29, 2025 · Common Stock
Kleiner Perkins Caufield & Byers Xiii, LLC
SCHEDULE 13G/A · filed Jun 8, 2026 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 11.5% in Jul 29, 2025
Tpg Gp A, LLC
SCHEDULE 13G/A · filed May 14, 2025 · Common Stock, $0.0001 par value per share · reported falling below 5%
What PGNY reports owning in othersstakes of 5% or more, and other ties
Progyny, Inc. reports no stake in another company in the record.
Insider tradesForm 4
37sales
1purchases
32sales on a scheduled plan
8people selling
$24.5Msold, in dollars
$1.9Mbought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 30 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Anevski Peter | CHIEF EXECUTIVE OFFICER | 8 | $14.7M | 8 | 1 | $1.9M |
| Schlanger David J | Executive Chairman | 3 | $7.1M | 3 | 0 | $0 |
| Livingston Mark S. | CHIEF FINANCIAL OFFICER | 8 | $900,000 | 8 | 0 | $0 |
| Gordon Kevin K | director | 3 | $800,000 | 0 | 0 | $0 |
| Cummings Melissa B | Chief Operating Officer | 3 | $400,000 | 3 | 0 | $0 |
| Swartz Allison | EVP, GC | 10 | $400,000 | 10 | 0 | $0 |
| Scott Cheryl | director | 1 | $200,000 | 0 | 0 | $0 |
| Clapp Geoffrey | Chief Product Officer | 1 | $0 | 0 | 0 | $0 |